Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2004 2
2005 1
2006 2
2010 1
2011 1
2013 1
2014 4
2015 2
2016 2
2017 5
2018 2
2019 6
2020 10
2021 5
2022 6
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Paller AS, Simpson EL, Siegfried EC, Cork MJ, Wollenberg A, Arkwright PD, Soong W, Gonzalez ME, Schneider LC, Sidbury R, Lockshin B, Meltzer S, Wang Z, Mannent LP, Amin N, Sun Y, Laws E, Akinlade B, Dillon M, Kosloski MP, Kamal MA, Dubost-Brama A, Patel N, Weinreich DM, Yancopoulos GD, O'Malley JT, Bansal A; participating investigators. Paller AS, et al. Among authors: lockshin b. Lancet. 2022 Sep 17;400(10356):908-919. doi: 10.1016/S0140-6736(22)01539-2. Lancet. 2022. PMID: 36116481 Clinical Trial.
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.
Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A. Simpson EL, et al. Among authors: lockshin b. JAMA Dermatol. 2020 Jan 1;156(1):44-56. doi: 10.1001/jamadermatol.2019.3336. JAMA Dermatol. 2020. PMID: 31693077 Free PMC article. Clinical Trial.
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy.
Paller AS, Siegfried EC, Simpson EL, Cork MJ, Lockshin B, Kosloski MP, Kamal MA, Davis JD, Sun X, Pirozzi G, Graham NMH, Gadkari A, Eckert L, Ruddy M, Bansal A. Paller AS, et al. Among authors: lockshin b. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):464-475. doi: 10.1111/jdv.16928. Epub 2020 Nov 8. J Eur Acad Dermatol Venereol. 2021. PMID: 32893393 Free PMC article. Clinical Trial.
Circumscribed plantar hypokeratosis.
Mitkov M, Balagula Y, Lockshin B. Mitkov M, et al. Among authors: lockshin b. Int J Dermatol. 2015 Jun;54(6):e203-5. doi: 10.1111/ijd.12598. Epub 2014 Jun 5. Int J Dermatol. 2015. PMID: 24898686 No abstract available.
When is cough functional, and how should it be treated?
Weinberger M, Lockshin B. Weinberger M, et al. Among authors: lockshin b. Breathe (Sheff). 2017 Mar;13(1):22-30. doi: 10.1183/20734735.015216. Breathe (Sheff). 2017. PMID: 28289448 Free PMC article. Review.
Dermatologic side effects of psychotropic medications.
Mitkov MV, Trowbridge RM, Lockshin BN, Caplan JP. Mitkov MV, et al. Among authors: lockshin bn. Psychosomatics. 2014 Jan-Feb;55(1):1-20. doi: 10.1016/j.psym.2013.07.003. Epub 2013 Oct 4. Psychosomatics. 2014. PMID: 24099686 Review.
Switching biologics in the treatment of psoriatic arthritis.
Merola JF, Lockshin B, Mody EA. Merola JF, et al. Among authors: lockshin b. Semin Arthritis Rheum. 2017 Aug;47(1):29-37. doi: 10.1016/j.semarthrit.2017.02.001. Epub 2017 Feb 8. Semin Arthritis Rheum. 2017. PMID: 28363434 Free article. Review.
Therapies for Psoriasis: Clinical and Economic Comparisons.
Marchetti A, Bhutani T, Lockshin B, Siegel DM, Behringer F. Marchetti A, et al. Among authors: lockshin b. J Drugs Dermatol. 2020 Nov 1;19(11):1101-1108. doi: 10.36849/JDD.2020.5510. J Drugs Dermatol. 2020. PMID: 33196750
48 results